Tower Research Capital (TRC)’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding PRAX
BBA
Tower Research Capital (TRC)'s PRAX Position: Q3 2026 in Review
Tower Research Capital (TRC) reduced its Praxis Precision Medicines (PRAX) stake by 27% in Q3 2026, selling an estimated $208K and leaving 1,693 shares worth $493K. The position accounts for 0.01% of the portfolio, ranked #1667.
Tower Research Capital (TRC) first reported a position in PRAX in Q4 2020 and has held it in 22 quarters since. The position peaked at $777K in Q2 2026. 339 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.
- Tower Research Capital (TRC) held 1,693 shares of Praxis Precision Medicines worth $493K as of Q3 2026.
- Tower Research Capital (TRC) sold 629 Praxis Precision Medicines shares in Q3 2026, an estimated $208K.
- Praxis Precision Medicines made up 0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #1667 holding.
- Tower Research Capital (TRC) first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 22 quarters since.
- Tower Research Capital (TRC)'s Praxis Precision Medicines position peaked at $777K in Q2 2026.
- 339 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.